These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3262701)

  • 41. Ketorolac (Toradol) and acute random-pattern skin flap survival in rat.
    Davis RE; Cohen JI; Robinson JE; Urben SL; Cook TA
    Arch Otolaryngol Head Neck Surg; 1995 Jun; 121(6):673-7. PubMed ID: 7772321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
    Roy SD; Manoukian E
    J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketorolac, an injectable nonnarcotic analgesic.
    Litvak KM; McEvoy GK
    Clin Pharm; 1990 Dec; 9(12):921-35. PubMed ID: 2292174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ketorolac: an injectable NSAID.
    DiPalma JR
    Am Fam Physician; 1991 Jan; 43(1):207-10. PubMed ID: 1986489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing.
    Wischnik A; Manth SM; Lloyd J; Bullingham R; Thompson JS
    Eur J Clin Pharmacol; 1989; 36(5):521-4. PubMed ID: 2787750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma prostaglandin E2 concentrations after single dose administration of ketorolac tromethamine (Toradol) in dogs.
    Pasloske K; Burger J; Conlon P
    Can J Vet Res; 1998 Jul; 62(3):237-40. PubMed ID: 9684056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketorolac and propofol administration for prevention of nausea and vomiting in patients undergoing minor gynecologic surgery.
    Hough MP; Waugaman WR
    Nurse Anesth; 1993 Mar; 4(1):9-17. PubMed ID: 8499507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlled evaluation of a bandage contact lens and a topical nonsteroidal anti-inflammatory drug in treating traumatic corneal abrasions.
    Donnenfeld ED; Selkin BA; Perry HD; Moadel K; Selkin GT; Cohen AJ; Sperber LT
    Ophthalmology; 1995 Jun; 102(6):979-84. PubMed ID: 7777307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Dec; 35(12):1324-30. PubMed ID: 9567769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery.
    Solomon KD; Turkalj JW; Whiteside SB; Stewart JA; Apple DJ
    Arch Ophthalmol; 1997 Sep; 115(9):1119-22. PubMed ID: 9298051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of ketorolac trometamol on renal function.
    Aitken HA; Burns JW; McArdle CS; Kenny GN
    Br J Anaesth; 1992 May; 68(5):481-5. PubMed ID: 1642936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contact lens induced conjunctivitis: a model of human ocular inflammation.
    Friedlaender MH
    CLAO J; 1996 Jul; 22(3):205-8. PubMed ID: 8828938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of diclofenac, ketorolac, and fluorometholone on arachidonic acid metabolites following excimer laser corneal surgery.
    Phillips AF; Hayashi S; Seitz B; Wee WR; McDonnell PJ
    Arch Ophthalmol; 1996 Dec; 114(12):1495-8. PubMed ID: 8953982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ketorolac for seasonal allergic conjunctivitis.
    Med Lett Drugs Ther; 1993 Sep; 35(905):88-9. PubMed ID: 8361452
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of a non-steroidal (ketorolac tromethamine) and a steroidal (dexamethasone) anti-inflammatory drug on refractive state and ocular growth.
    Luu CD; Foo H; Crewther SG; Crewther DP
    Clin Exp Ophthalmol; 2001 Jun; 29(3):175-8. PubMed ID: 11446463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastric ulcer perforation associated with the use of injectable ketorolac.
    Estes LL; Fuhs DW; Heaton AH; Butwinick CS
    Ann Pharmacother; 1993 Jan; 27(1):42-3. PubMed ID: 8431619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of ketorolac tromethamine on clot elastic strength in humans as assessed by thromboelastography.
    Reinhart DJ; Latson TW; Whitten CW; Klein KW; Allison PM; Patel M
    J Clin Anesth; 1993; 5(3):216-20. PubMed ID: 8318240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ketorolac: a parenteral nonsteroidal antiinflammatory drug.
    Resman-Targoff BH
    DICP; 1990 Nov; 24(11):1098-104. PubMed ID: 2275236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastrointestinal complications associated with intramuscular ketorolac tromethamine therapy in the elderly.
    Maliekal J; Elboim CM
    Ann Pharmacother; 1995; 29(7-8):698-701. PubMed ID: 8520083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous absorption of nicardipine and ketorolac in rhesus monkeys.
    Yu D; Sanders LM; Davidson GW; Marvin MJ; Ling T
    Pharm Res; 1988 Jul; 5(7):457-62. PubMed ID: 3266795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.